# Safety and Pharmacokinetic Study of ARTS-011 in Chinese Healthy Volunteers

> **NCT06260527** · PHASE1 · COMPLETED · sponsor: **Allorion Therapeutics Inc** · enrollment: 76 (actual)

## Conditions studied

- Chinese Healthy Volunteer

## Interventions

- **DRUG:** ARTS-011
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT06260527
- **Lead sponsor:** Allorion Therapeutics Inc
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2023-08-29
- **Primary completion:** 2024-03-28
- **Final completion:** 2024-03-28
- **Target enrollment:** 76 (ACTUAL)
- **Last updated:** 2024-07-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06260527

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06260527, "Safety and Pharmacokinetic Study of ARTS-011 in Chinese Healthy Volunteers". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT06260527. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*